95
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Preparation and characterization of triamterene complex with ascorbic acid derivatives

, , , , , , & show all
Pages 2032-2040 | Received 13 Aug 2020, Accepted 21 Oct 2020, Published online: 01 Nov 2020

References

  • Grosso G, Bei R, Mistretta A, et al. Effects of vitamin C on health: a review of evidence. Front Biosci (Landmark Ed). 2013;18(3):1017–1029.
  • Telang P. Vitamin C in dermatology. Indian Dermatol Online J. 2013;4(2):143–146.
  • Ferrer EG, Williams PAM, Baran EJ. Interaction of the vanadyl(IV) cation with L-ascorbic acid and related systems. Chemistry. 1998;53:256–262.
  • Yamamoto K. [Course in development of a stable vitamin C derivative (AA-2G)]). Nihon Yakurigaku Zasshi. 2008;132(3):160–165.
  • Ochiai Y, Kaburagi S, Obayashi K, et al. A new lipophilic pro-vitamin C, tetra-isopalmitoyl ascorbic acid (VC-IP), prevents UV-induced skin pigmentation through its anti-oxidative properties . J Dermatol Sci. 2006;44(1):37–44.
  • Fujinami Y, Tai A, Yamamoto I. Radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl of ascorbic acid 2-glucoside (AA-2G) and 6-acyl-AA-2G. Chem Pharm Bull (Tokyo)). 2001;49(5):642–644.
  • Yamamoto I, Suga S, Mitoh Y, et al. Antiscorbutic activity of L-ascorbic acid 2-glucoside and its availability as a vitamin C supplement in normal rats and guinea pigs. J Pharmacobiodyn. 1990;13(11):688–695.
  • Kwon T, Kim CT, Lee JH. Transglucosylation of ascorbic acid to ascorbic acid 2-glucoside by a recombinant sucrose phosphorylase from Bifidobacterium longum. Biotechnol Lett. 2007;29(4):611–615.
  • Niki E, Saito T, Kawakami A, et al. Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C. J Biol Chem. 1984;259(7):4177–4182.
  • Caritá AC, Fonseca-Santos B, Shultz JD, et al. Vitamin C: one compound, several uses. Advances for delivery, efficiency and stability. Nanomedicine. 2019;30:102117.
  • Takebayashi J, Tai A, Yamamoto I. Long-term radical scavenging activity of AA-2G and 6-acyl-AA-2G against 1,1-diphenyl-2-picrylhydrazyl. Biol Pharm Bull. 2002;25(11):1503–1505.
  • Chen R, Okamoto H, Danjo K. Particle design using a 4-fluid-nozzle spray-drying technique for sustained release of acetaminophen. Chem Pharm Bull (Tokyo)). 2006;54(7):948–953.
  • Maher HM, Youssef RM, El-Kimary EI, et al. Bioavailability study of triamterene and xipamide using urinary pharmacokinetic data following single oral dose of each drug or their combination. J Pharm Biomed Anal. 2012;61:78–85.
  • Mukne AP, Nagarsenker MS. Triamterene-ß-cyclodextrin systems: Preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 2004;25(142):E19.
  • Suzuki R, Inoue Y, Tsunoda Y, et al. Effect of γ-cyclodextrin derivative complexation on the physicochemical properties and antimicrobial activity of hinokitiol. J Incl Phenom Macrocycl Chem. 2015;83(1-2):177–186.
  • Abu TMS. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 2007;59:603–616.
  • Abdulmajed K, Heard CM. Topical delivery of retinyl ascorbate co-drug. 1. Synthesis, penetration into and permeation across human skin. Int J Pharm. 2004;280(1-2):113–124.
  • Pas T, Verbert S, Appeltans B, et al. The influence of crushing amorphous solid dispersion dosage forms on the in-vitro dissolution kinetics. Int J Pharm. 2020;573:1–10.
  • Li A-Y, Xu L-L, Chen J-M, et al. Solubility and dissolution rate enhancement of triamterene by a cocrystallization method. Cryst Growth Des. 2015;15(8):3785–3791.
  • Singh G, Mohanty BP, Saini GS. Structure, spectra and antioxidant action of ascorbic acid studied by density functional theory, Raman spectroscopic and nuclear magnetic resonance techniques. Spectrochim Acta A Mol Biomol Spectrosc. 2016;155:61–74.
  • Martínez LM, Videa M, Sosa NG, et al. Long-term stability of new co-amorphous drug binary systems: Study of glass transitions as a function of composition and shelf time. Molecules. 2016;21(12):1712.
  • Karagianni A, Kachrimanis K, Nikolakakis I. Co-amorphous solid dispersions for solubility and absorption improvement of drugs: composition, preparation, characterization and formulations for oral delivery. Pharmaceutics. 2018;10(3):98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.